Maine

On this page

Tables and graphs report on cancer screening services provided through the program in a recent 5-year period. The data represent clinical services funded directly through the NBCCEDP as reported in the April 2010 submission of the NBCCEDP Minimum Data Elements (MDE).

National aggregate data are typically used to report results from the program and as a standard to compare results of grantee programs. Comparing data across grantee programs is not advised due to extensive variation across programs. For information on interpreting the data, refer to Screening Program Data. For information on the program, refer to About the Program.

Program Overview

Women Served through the NBCCEDP
Five-Year Summary, 7/2004 to 6/2009
Maine
Women served* 10,785
Women screened** 10,759
Women receiving mammography 8,889
Women receiving Pap tests 7,731
Each category reports counts of unduplicated women receiving services within the 5-year period. Women may be counted in more than one category.

* Women served includes women receiving any NBCCEDP-funded screen or diagnostic procedure.

** Women screened includes women receiving any NBCCEDP-funded screen (mammography, clinical breast exam, or Pap test).

Data Source: April 2010 submission of NBCCEDP Minimum Data Elements (MDE)

Cervical Cancer Screening

Distribution by Race/Ethnicity
Five-Year Summary, 7/2004 to 6/2009
Maine
This pie chart illustrates the percent distribution of women who received NBCCEDP-funded Pap tests by race/ethnicity from 7/2004 to 6/2009.
Women receiving an NBCCEDP-funded Pap test = 7,731
Distribution by Age
Five-Year Summary, 7/2004 to 6/2009
Maine
This pie chart illustrates the percent distribution of women who received NBCCEDP-funded Pap tests by age from 7/2004 to 6/2009.
Women receiving an NBCCEDP-funded Pap test = 7,731
See text description of these graphs.


Cervical Cancer Screening Results and Outcomes
Five-Year Summary, 7/2004 to 6/2009
Maine
Pap tests provided 13,535
Pap tests with abnormal results* 289
     Percentage of Pap tests with abnormal results 2.1
     Age-adjusted percentage** 2.5
Cervical cancers or cancer precursor lesions detected*** 113
     CIN-1 or LSIL 63
     CIN-2 or worse**** 50
     Rate of CIN-2 or worse detected per 1,000 Pap tests**** 3.7
     Age-adjusted rate per 1,000 Pap tests** 8.0
* Abnormals include Pap test results of: low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical squamous cells of undetermined significance – cannot exclude HSIL (ASC-H), atypical glandular cells (AGC), and squamous cell cancer.

** Adjusted to the age distribution of NBCCEDP participants having Pap tests performed in calendar year 2000.

*** Includes LSIL, HSIL, cervical intraepithelial neoplasia (CIN)-1, CIN-2, CIN-3, carcinoma in situ (CIS), and invasive cervical cancer.

**** Includes HSIL, CIN-2, CIN-3, CIS, and invasive cervical cancer.

Table includes only NBCCEDP-funded Pap tests.

Breast Cancer Screening

Distribution by Race/Ethnicity
Five-Year Summary, 7/2004 to 6/2009
Maine
This pie chart illustrates the percent distribution of women who received NBCCEDP-funded mammograms by race/ethnicity from 7/2004 to 6/2009.
Women receiving an NBCCEDP-funded mammogram = 8,889
Distribution by Age
Five-Year Summary, 7/2004 to 6/2009
Maine
This pie chart illustrates the percent distribution of women who received NBCCEDP-funded mammograms by age from 7/2004 to 6/2009.
Women receiving an NBCCEDP-funded mammogram = 8,889
See text description of these graphs.


Breast Cancer Screening Results and Outcomes
Five-Year Summary, 7/2004 to 6/2009
Maine
Mammograms provided 17,147
Abnormal mammograms* 1,627
     Percentage of abnormal mammograms 9.5
     Age-adjusted percentage** 9.4
Breast cancers detected*** 116
     Rate of breast cancers detected per 1,000 mammograms 6.8
     Age-adjusted rate per 1,000 mammograms** 6.9
* Abnormals include mammogram results of: suspicious abnormality, highly suggestive of malignancy, and assessment incomplete (further imaging studies or film comparisons required).

** Adjusted to the age distribution of NBCCEDP participants 40 years of age and older having mammograms performed in calendar year 2000.

*** Breast cancers include invasive breast cancer, ductal carcinoma in situ (DCIS), and other in situ excluding lobular carcinoma in situ (LCIS).

Table includes only NBCCEDP-funded mammograms provided to women age 40 and older. Additionally, less than 16 women, not included above, were diagnosed with CIS (other), DCIS, or invasive breast cancer through the NBCCEDP following a mammogram funded through another source.

Text Description of Cervical Cancer Screening Graphs

Distribution by Race/Ethnicity
Five-Year Summary, 7/2004 to 6/2009
Maine
Race Percentage
White 95.4
Black 0.5
Asian/Pacific Islander 0.8
American Indian/Alaska Native 1.0
Multiracial 0.7
Hispanic 1.4
Unknown 0.2
Women receiving an NBCCEDP-funded Pap test = 7,731


Distribution by Age
Five-Year Summary, 7/2004 to 6/2009
Maine
Age Percentage
<30 0.0
30–39 0.4
40–49 45.1
50–64 54.1
65+ 0.5
Unknown 0.0
Women receiving an NBCCEDP-funded Pap test = 7,731

Return to the Cervical Cancer Screening section

Text Description of Breast Cancer Screening Graphs

Distribution by Race/Ethnicity
Five-Year Summary, 7/2004 to 6/2009
Maine
Race Percentage
White 95.5
Black 0.5
Asian/Pacific Islander 0.8
American Indian/Alaska Native 1.1
Multiracial 0.6
Hispanic 1.4
Unknown 0.1
Women receiving an NBCCEDP-funded mammogram = 8,889


Distribution by Age
Five-Year Summary, 7/2004 to 6/2009
Maine
Age Percentage
<40 0.3
40–49 31.5
50–64 67.4
65+ 0.8
Unknown 0.0
Women receiving an NBCCEDP-funded mammogram = 8,889

Return to the Breast Cancer Screening section